Table 2.
Indications or experiences with kidney biopsy for patients with concomitant proteinuria and hematuria
| Urinary protein | ||||||||
|---|---|---|---|---|---|---|---|---|
| CKD G stage | ≥ 0.15 g/day (%) | ≥ 0.5 g/day (%) | ≥ 1 g/day (%) | ≥ 3.5 g/day (%) | ||||
| NF | PF | NF | PF | NF | PF | NF | PF | |
| G1 (eGFR > 90) | 64 | 52 | 96 | 100 | 99 | 100 | 99 | 100 |
| G2 (eGFR 60–90) | 67 | 65 | 98 | 92 | 100 | 92 | 100 | 92 |
| G3 (eGFR 30–60) | 61 | 62 | 91 | 79 | 97 | 79 | 98 | 79 |
| G4 (eGFR 15–30) | 32 | 38 | 48 | 48 | 58 | 50 | 68 | 52 |
| G5 (eGFR < 15) | 15 | 25 | 25 | 31 | 30 | 31 | 39 | 33 |
NF nephrology facilities for adult patients, PF pediatric nephrology facilities for child and adolescent patients